Grants per year
Search results
-
Finished
Community Counts: Public Health Surveillance for Bleeding Disorders
Zakarija, A. (PD/PI)
Great Lakes Hemophilia Foundation, Centers for Disease Control and Prevention
9/30/15 → 9/29/20
Project: Research project
-
Hemophilia Treatment Center (HRSA Award)
Zakarija, A. (PD/PI)
Great Lakes Hemophilia Foundation, Health Resources and Services Administration
6/1/14 → 5/31/16
Project: Research project
-
ATHN Data Quality Counts Award Round 5.1
Zakarija, A. (PD/PI)
American Thrombosis and Hemostasis Network
4/30/13 → 4/29/14
Project: Research project
-
Hemophilia Treatment Center (HRSA Award)
Zakarija, A. (PD/PI)
Great Lakes Hemophilia Foundation, Health Resources and Services Administration
6/1/12 → 5/31/14
Project: Research project
-
Prevention of the Complications of Bleeding Through HTC's
Zakarija, A. (PD/PI)
Great Lakes Hemophilia Foundation, Centers for Disease Control and Prevention
9/30/11 → 9/29/15
Project: Research project
-
A Multi-Center, Randomized Study of Cyclosporine or Corticosteroid As An Adjunct to Plasma Exchange In Initial Therapy of TTP (Neoral, IND# 78,687)
Zakarija, A. (PD/PI)
Ohio State University, Food and Drug Administration
8/15/11 → 7/31/13
Project: Research project
-
Prot# ARC1779-006: A Randomized, Double-Blind, Placebo-Controlled, Clinical Outcome Study of ARC1779 Injection in Patients with Thrombotic Microangiopathy
Zakarija, A. (PD/PI)
Worldwide Clinical Trials, Inc., Archemix Corp.
12/16/08 → 12/15/11
Project: Research project
-
Prot# 12800: Randomized, Controlled, Parallel, Prospective Trial to Evaluate the Effect of Secondary Prophylaxis with rFVIII Therapy in Severe Hemophilia A Adult Subjects Compared to That of Episodic Treatment (SPINART)
Zakarija, A. (PD/PI)
PPD Development, Bayer Corporation
9/29/08 → 12/31/16
Project: Research project
-
Prot# UNI-108: A Blinded Non-Inferiority Study to Compare UNIPLAS with Cryosupernatant Plasms in Thrombotic Thrombocytopenic Purpura (TTP)
Davidson, C. J. (PD/PI), Ramsey, G. E. (Co-PD/PI) & Zakarija, A. (Co-PD/PI)
9/5/07 → 9/5/10
Project: Research project
-
Prot# ICA-17043-10: Phz 3, Mltctr, 52-Wk, Rndmzd, Dbl-Bld, Plcbo-Cntrld Study of Clinical E & S of ICA-17043 w/ or w/out Hydroxyurea Therapy in Patients w/ Sickle Cell Disease Who Have Had >=2 Acute Sickle-Related Painful Crises w/in Preceding 12 Mnths
Zakarija, A. (PD/PI)
1/6/06 → 12/1/11
Project: Research project
-
Tissue Factor Expression in Brain Tumors
Zakarija, A. (PD/PI) & Chandler, J. P. (Co-PD/PI)
Northwestern Memorial Hospital, Illinois Department of Healthcare and Family Services
9/1/04 → 8/31/07
Project: Research project
-
Prot# M02-446: A Phase II Study of ABT-751 in Subjects with Refractory Colorectal Carcinoma
Benson III, A. B. (PD/PI), Flaum, L. E. (Other), Frankfurt, O. (Other) & Zakarija, A. (Other)
4/29/04 → 4/29/06
Project: Research project
-
Prot# MNTX 301: A Double-Blind Placebo Controlled Study of Methylnaltrexone (MNTX) for the Relief of Symptomatic Constipation Due to Chronic Opioid Therapy in Patients with Advanced Medical Illness
Flaum, L. E. (Other), Frankfurt, O. (Other) & Zakarija, A. (Other)
Progenics Pharmaceuticals, Inc.
4/7/04 → 4/5/07
Project: Research project
-
Prot# MNTX 301: A Double-Blind Placebo Controlled Study of Methylnaltrexone (MNTX) for the Relief of Symptomatic Constipation Due to Chronic Opioid Therapy in Patients with Advanced Medical Illness
Flaum, L. E. (Other), Frankfurt, O. (Other) & Zakarija, A. (Other)
Progenics Pharmaceuticals, Inc.
4/7/04 → 4/5/07
Project: Research project
-
Prot# NCI R03L1: A Phase 2 Study of OSI 774 (IND# 63383) in Combination with Celecoxib (Celebrex, Pharmacia) as Second-Line Therapy in Advanced Non-Small Cell Lung Cancer (NCI prot# 5416) (Rush prot# Lung 2002-1)
Patel, J. D. (PD/PI), Flaum, L. E. (Other), Frankfurt, O. (Other) & Zakarija, A. (Other)
Rush University Medical Center, Pfizer Inc.
3/22/04 → 1/1/08
Project: Research project
-
Prot# NCI R03L1: A Phase 2 Study of OSI 774 (IND# 63383) in Combination with Celecoxib (Celebrex, Pharmacia) as Second-Line Therapy in Advanced Non-Small Cell Lung Cancer (NCI prot# 5416) (Rush prot# Lung 2002-1)
Patel, J. D. (PD/PI), Flaum, L. E. (Other), Frankfurt, O. (Other) & Zakarija, A. (Other)
Rush University Medical Center, Pfizer Inc.
3/22/04 → 1/1/08
Project: Research project
-
Prot# PSIND011: Mltctr Phz 1-2 Trial to Evaluate E&S of IDEC-Y2B8 (Zevalin) Radioimmunotherapy in Low-Grade, Follicular or Transformed B-Cell Non-Hodgkin's Lymphoma Patients Following Initial Response & Subsequent Relapse from Previous (NU Prot# UAB 0153)
Gordon, L. I. (PD/PI), Flaum, L. E. (Other), Frankfurt, O. (Other) & Zakarija, A. (Other)
University of Alabama Medical School, Biogen Inc.
3/4/04 → 2/28/06
Project: Research project
-
Prot# 9238IL/0048: Rndmzd, Dbl-Bld, Mltctr Study to Compare Effic & Tolrblty of Fulvestrant (FASLODEX?) vs Exemestane (AROMASIN?) in Postmenopausal Women w/ Hormone Receptor Positive Advanced Breast Cancer w/ Disease Progression after Prior Non-Steroidal
Gradishar, W. J. (PD/PI), Flaum, L. E. (Other), Frankfurt, O. (Other) & Zakarija, A. (Other)
2/18/04 → 11/21/11
Project: Research project
-
Prot# OSI2542s: Multicenter Phase II Trial of OSI-774 (Erlotinib, Tarceva?) in Patients with Advanced Bronchioloalveolar Cell Lung Cancer (NU Prot# NU MSK03L1)
Patel, J. D. (PD/PI), Flaum, L. E. (Other), Frankfurt, O. (Other) & Zakarija, A. (Other)
2/5/04 → 12/8/11
Project: Research project
-
Prot# EDOAGL-8725-001: A Phase III, Randomized, Open-Label Study of IV Edotecarin vs. Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients w/Glioblastoma Multiforme that has Progressed/Recurred after Alkylator-Based (Neo)Adjuvant Chemotherapy
Raizer, J. J. (PD/PI), Flaum, L. E. (Other), Frankfurt, O. (Other) & Zakarija, A. (Other)
2/4/04 → 12/6/05
Project: Research project
-
Prot# TPU-S1101: A Phase I/II, Open-Label, Nonrandomized, Dose-Finding, Safety, Tolerance, Pharmacokinetic and Efficacy Study of Orally Administered S-1 in Combination with Cisplatin in Patients with Advanced Gastric Cancer
Benson III, A. B. (PD/PI), Flaum, L. E. (Other), Frankfurt, O. (Other) & Zakarija, A. (Other)
1/1/04 → 11/1/11
Project: Research project
-
Prot# Hx-CD4-008: An Open-Label Therapeutic Exploratory Clinical Trial of HuMax-CD4, A Fully Human Monoclonal Anti-CD4 Antibody, in Patients with Advanced Stage (IIA-IVB) Cutaneous T-Cell Lymphoma
Kuzel, T. M. (PD/PI) & Zakarija, A. (Co-PD/PI)
11/13/03 → 3/30/04
Project: Research project
-
Prevention of the Complications of Hemophilia through Hemophilia Treatment Centers, The Region V - West Program
Zakarija, A. (PD/PI)
Great Lakes Hemophilia Foundation, Centers for Disease Control and Prevention
9/30/02 → 9/29/11
Project: Research project
-
West Hemophilia Treatment Center Network, Region V--MCHB Cooperative Grant
Zakarija, A. (PD/PI)
Great Lakes Hemophilia Foundation, Maternal and Child Health Bureau
6/1/02 → 5/31/12
Project: Research project